*Retatrutide is investigational and not yet FDA-approved
Robinson in North America, commented, "You need to really have that end-to-end connectivity, so you've got to have a really nice network and infrastructure built out in order to properly service the healthcare customers." He noted that with the rise of GLP-1s, "it's really creating a competitive nature for the same refrigerated supply resources that are there and, quite candidly, that supply is not unlimited, it's constrained." Hendrik Venter, who leads DHL Supply Chain, observed that healthcare logistics innovation is converging with advancements in artificial intelligence
Appetite returns, old patterns re-emerge, and cardiometabolic risk can creep back
The path forward requires continued investment, continued collaboration, and continued focus on bringing new therapeutic options to patients living with Type 1 Diabetes
Heres how to manage them effectively